BCDA - BioCardia, Inc.
2.85
0 0%
Share volume: 51,670
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$2.85
0.00
0.00%
Summary score
30%
Profitability
43%
Dept financing
20%
Liquidity
53%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-37.89%
Return on assets
-44.49%
Return on sales
-3316.18%
Return on invested capital
55.02%
Total debt ratio
49.59%
Debt ratio change over timeo
0%
Current Ratio
7.99%
Quick Ratio
4.72%
Cash Position Ratio
7.89%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
22.08%
Return on assets
-52.15%
Return on sales
-5145.51%
Return on invested capital
128.56%
Total debt ratio
73.56%
Debt ratio change over timeo
0%
Current Ratio
1.81%
Quick Ratio
1.93%
Cash Position Ratio
1.65%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-49.01%
Return on assets
-27.22%
Return on sales
0%
Return on invested capital
101.53%
Total debt ratio
44.46%
Debt ratio change over time
0%
Current Ratio
2.66%
Quick Ratio
0%
Cash Position Ratio
2.44%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | BCDA | AMGN | GILD | BNTX |
---|---|---|---|---|
Return on equity | -37.89% | 11.55% | 5.76% | -13.17% |
Return on assets | -44.49% | 3.57% | 4.02% | -8.16% |
Return on sales | -3316.18% | 42.16% | 39.53% | -204.65% |
Return on invested capital | 55.02% | 7.99% | 5.61% | -53.4% |
Profitability | 25% | 76% | 63% | 0% |
Total debt ratio | 49.59% | 74.11% | 65.71% | 38.48% |
Debt ratio change over time | 0% | 0% | 376.49% | 0% |
Dept financing | 17% | 25% | 47% | 13% |
Current Ratio | 1.81% | 2.02% | 2.86% | 3.17% |
Quick Ratio | 1.93% | 1.71% | 2.76% | 3.11% |
Cash Position Ratio | 1.65% | 0.76% | 2.25% | 2.96% |
Liquididy | 75% | 31% | 31% | 36% |
Short-term ratios | BCDA | AMGN | GILD | BNTX |
---|---|---|---|---|
Return on equity | 22.08% | 17.94% | -1.29% | -13.17% |
Return on assets | -52.15% | 3.67% | 1.51% | -8.16% |
Return on sales | -5145.51% | 37.5% | 16.39% | -204.65% |
Return on invested capital | 128.56% | 7.17% | -0.65% | -53.4% |
Profitability | 50% | 72% | 21% | 0% |
Total debt ratio | 73.56% | 83.42% | 64.86% | 38.48% |
Debt ratio change over time | 0% | 0% | 1.76% | 0% |
Dept financing | 22% | 25% | 44% | 12% |
Current Ratio | 1.81% | 2.02% | 2.86% | 3.17% |
Quick Ratio | 1.93% | 1.71% | 2.76% | 3.11% |
Cash Position Ratio | 1.65% | 0.76% | 2.25% | 2.96% |
Liquididy | 44% | 36% | 64% | 75% |